nivolumab
bms
['nivolumab', 'crpc', 'nivo', 'biomarker']
overall survival and biomarker results from combat: a phase 2 study of bipolar androgen therapy + nivolumab for patients with #mcrpc. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology